scispace - formally typeset
M

Muneeb A. Faiq

Researcher at New York University

Publications -  75
Citations -  1855

Muneeb A. Faiq is an academic researcher from New York University. The author has contributed to research in topics: Glaucoma & Intraocular pressure. The author has an hindex of 18, co-authored 70 publications receiving 1106 citations. Previous affiliations of Muneeb A. Faiq include Center for Neural Science & University of Delhi.

Papers
More filters
Journal ArticleDOI

Oxidative stress and male infertility

TL;DR: Lifestyle interventions including yoga and meditation can substantially improve the integrity of sperm DNA by reducing levels of oxidative DNA damage, regulating oxidative stress and by increasing the expression of genes responsible for DNA repair, cell-cycle control and anti-inflammatory effects.
Journal ArticleDOI

Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma

Chiea Chuen Khor, +251 more
- 01 May 2016 - 
TL;DR: It is confirmed that significant association at three previously described loci (P < 5 × 10−8 for each sentinel SNP at PLEKHA7, COL11A1, and PCMTD1–ST18), providing new insights into the biology of PACG, is confirmed.
Journal ArticleDOI

Mental stress as consequence and cause of vision loss: the dawn of psychosomatic ophthalmology for preventive and personalized medicine.

TL;DR: It is concluded that stress is both consequence and cause of vision loss, and stress reduction and relaxation techniques (e.g., meditation, autogenic training, stress management training, and psychotherapy to learn to cope) should be recommended not only as complementary to traditional treatments of sight loss but possibly as preventive means to reduce progression of vision Loss.
Journal ArticleDOI

Cholinergic nervous system and glaucoma: From basic science to clinical applications

TL;DR: Citicoline is a naturally occurring compound and FDA approved dietary supplement that is recently demonstrated to be effective in ameliorating ischemic stroke, traumatic brain injury, Parkinson's disease, Alzheimer’s disease, cerebrovascular diseases, memory disorders and attention-deficit/hyperactivity disorder in both humans and animal models.
Journal ArticleDOI

Yoga- and meditation-based lifestyle intervention increases neuroplasticity and reduces severity of major depressive disorder: A randomized controlled trial.

TL;DR: YMLI can be considered as a therapeutic intervention in MDD management and is associated with improved systemic biomarkers of neuroplasticity, including mind-body communicative and cellular health biomarkers.